IRIS
CHIAZZA, FAUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.984
NA - Nord America 1.742
AS - Asia 526
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 4.257
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.742
IE - Irlanda 842
DE - Germania 364
SE - Svezia 322
UA - Ucraina 295
CN - Cina 259
SG - Singapore 122
HK - Hong Kong 96
IT - Italia 82
FR - Francia 46
VN - Vietnam 19
IN - India 18
BE - Belgio 16
TR - Turchia 7
GB - Regno Unito 5
FI - Finlandia 4
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
JP - Giappone 2
PL - Polonia 2
CL - Cile 1
CZ - Repubblica Ceca 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 4.257
Salva come PNG Salva come JPEG
Città #
Dublin 842
Jacksonville 595
Dearborn 372
Bremen 106
Lawrence 106
Princeton 106
Wilmington 102
Hong Kong 96
Ann Arbor 93
San Mateo 92
Beijing 89
Singapore 72
Ashburn 27
Kunming 25
Nanjing 24
Piemonte 21
Dong Ket 18
Hefei 17
Brussels 15
Santa Clara 13
Fairfield 10
Jinan 10
Norwalk 10
Chandler 8
Guangzhou 7
Kocaeli 7
Nanchang 7
Shenyang 7
Munich 6
Wuhan 6
Fuzhou 5
Hangzhou 5
Houston 5
Milan 5
Roasio 5
Sezze 5
Zhengzhou 5
Andover 4
Chongqing 4
Turin 4
Vercelli 4
Chengdu 3
Lappeenranta 3
Novara 3
Wenzhou 3
Asyut 2
Baotou 2
Biella 2
Busto Arsizio 2
Casalecchio di Reno 2
Grafing 2
Hebei 2
Leawood 2
Monmouth Junction 2
Monza 2
Naples 2
Ningbo 2
Quzhou 2
Sangano 2
Seattle 2
Shanghai 2
Strasbourg 2
Taizhou 2
Tianjin 2
Tokushima 2
Woodbridge 2
Xian 2
Amsterdam 1
Boston 1
Brescia 1
Changsha 1
Chaoyang 1
Como 1
Fremont 1
Guiyang 1
Harbin 1
Huzhou 1
Langfang 1
Lommel 1
L’Aquila 1
Messina 1
Mülheim 1
Nanning 1
North Finchley 1
Nuremberg 1
Oslo 1
Prague 1
Rome 1
San Diego 1
Shaoxing 1
Shenzhen 1
Taiyuan 1
Tashkent 1
Torino 1
Vientiane 1
Zanjan 1
Totale 3.045
Salva come PNG Salva come JPEG
Nome #
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages 80
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 69
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells 67
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells 58
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. 56
A short bout of HFD promotes long-lasting hepatic lipid accumulation 56
Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice. 56
ROLE OF THE beta-D-ENDOGLUCURONIDASE HEPARANASE IN SEPTIC CARDIOMYOPATHY 54
A nonerythropoietic peptide analog of erythropoietin decreases susceptibility to diet-induced insulin resistance 50
A NOVEL SYNTHETIC, HOST-DEFENCE PEPTIDE PROTECTS AGAINST ORGAN INJURY/DYSFUNCTION IN A RAT-MODEL OF SEVERE HEMORRHAGIC SHOCK 49
Beneficial effects of relaxin in an in vivo experimental model of ischemic acute kidney injury 49
The effect of the DPP-4 inhibitor Linagliptin to improve functional outcome after stroke is mediated by the CXCR4/SDF-1α pathway 49
SALIVAGE – EU JPI Project The “form” makes the difference: unrevealing the differential impact of liquid and solid fructose in mice metabolic signatures by comprehensive two-dimensional gas chromatography 48
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 48
Effects of empagliflozin in a murine model of diet-induced insulin resistance: A role for NLRP3 inflammasome inhibition? 48
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages 47
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 47
A Selective IκB Kinase Inhibitor (IKK16) Attenuates The Organ Injury / Dysfunction Associated With Haemorrhagic Shock In The Rat 47
Hepatocyte-derived microparticles promote NLRP3 inflammasome activation in HepG2 cells 47
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 47
The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the CXCR4/SDF-1alpha pathway 46
Effects of Vitamin D on insulin resistance and myosteatosis in diet-induced obese mice 46
The Stroke-Induced Increase of Somatostatin-Expressing Neurons is Inhibited by Diabetes: A Potential Mechanism at the Basis of Impaired Stroke Recovery 46
A novel synthetic, host-defence peptide protects against organ injury/dysfunction in a rat-model of severe hemorrhagic shock 45
Exacerbation of myocardial ischemia/reperfusion injury induced by high-fat-high-fructose (HFHF) diet: Role of NLRP3 inflammasome 45
Artesunate protects against the organ injury and dysfunction induced by severe hemorrhage and resuscitation 45
Endogenous annexin-A1 is a protective determinant in high-fat diet (HFD)-induced insulin resistance and diabetic nephropathy 45
Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles 45
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 45
A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice 45
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 45
Endogenous Annexin-A1 is a Protective Determinant in HFD-induced Insulin Resistance and Diabetic Nephropathy 45
DUAL SECOND DIMENSION COLUMN-DUAL DETECTION IN TWO-DIMENSIONAL COMPREHENSIVE GAS CHROMATOGRAPHY (GC×2GC-MS/FID): INCREASED INFORMATION IN OPTIMIZED SEPARATION CONDITIONS IN METABOLOMICS 44
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD 44
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes 44
The ages inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 43
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 43
Artesunate Protects Against the Organ Injury and Dysfunction Induced by Severe Hemorrhage and Resuscitation 43
Pre-existing chronic kidney disease worsens the myocardial dysfunction caused by sepsis in mice 43
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 43
The NLRP3 inflammasome as a new pharmacological target in myocardial ischemia/reperfusion injury in the adult rat 43
Role of the β-D-endoglucuronidase heparanase in septic cardiomyopathy 43
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR- δ Agonism 42
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 42
The cardiac dysfunction caused by sepsis in animals with chronic kidney disease is attenuated by inhibiting I kappa B kinase 42
Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat 42
The effect of the DPP-4 inhibitor linagliptin to improve functional outcome after stroke is mediated by the CXCR4/SDF-1α pathway 42
Pharmacological inhibition of IκB Kinase reduces the multiple organ dysfunction associated with hemorrhagic shock in rat 41
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle 41
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 41
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: any differences between solid and liquid formulations? 41
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 41
The anti-inflammatory protein Annexin A1 as new pharmacological approach to counteract the deleterious effects of diet-induced metabolic derangements 41
Short high fat diet triggers reversible and region specific effects in DCX+ hippocampal immature neurons of adolescent male mice 41
Scavenging circulating mitochondrial DNA as a potential therapeutic option for multiple organ dysfunction in trauma hemorrhage 40
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation 40
Fructose-Derived Advanced Glycation End-Products Evoke Skeletal Muscle Damage in Mice by Multiple Interference with SCAP-SREBP Pathway 39
Artesunate Protects Against the Organ Injury and Dysfunction Induced by Severe Hemorrhage and Resuscitation 39
Neuronal nitric oxide synthase is involved in vascular hyporeactivity and multiple organ dysfunction associated with hemorrhagic shock 39
Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury 39
The effect of the DPP-4 inhibitor linagliptin to improve functional outcome after stroke is mediated by the CXCR4/SDF-1α pathway. 39
The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway 39
Inflammatory signaling and insulin resistance caused by sugar intake: modulation by PPAR-δ agonism 39
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin 39
TRAUMA ORGAN PROTECTION WITH ARTESUNATE (TOP-ART): PRECLINICAL EFFICACY OF AN ANTIMALARIAL DRUG WITH EXCELLENT SAFETY PROFILE AND PLANNED PHASE II RCT 38
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 38
Gender dimorphism of the cardiac dysfunction in murine sepsis: Signalling mechanisms and age-dependency 38
Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons 38
Role of NLRP3 inflammasome in a mouse model of diet-induced exacerbation of myocardial ischemia/reperfusion injury 37
Vitamin D improves insulin sensitivity and myosteatosis in a model of diet-induced insulin resistance 37
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 37
The cardiac dysfunction caused by sepsis in animals with chronic kidney disease is attenuated by inhibiting I kappa B kinase 37
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 37
Peroxisome proliferator activated receptors in glucose control 37
Novel Synthetic, Host-defense Peptide Protects Against Organ Injury/Dysfunction in a Rat Model of Severe Hemorrhagic Shock 37
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways 36
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 36
Urinary metabolic fingerprinting of mice with diet-induced metabolic derangements by parallel dual secondary column-dual detection two-dimensional comprehensive gas chromatography 36
‘Preconditioning’ with Low Dose Lipopolysaccharide Aggravates the Organ Injury / Dysfunction Caused by Hemorrhagic Shock in Rats 36
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 36
Pharmacological inhibition of NLRP3 inflammasome exerts beneficial effects against ischaemia/reperfusion injury in the rat heart by local improvement of protective signaling pathways 35
Inhibition of ÎkB kinase at 24 hours after acute kidney injury improves recovery of renal function and attenuates fibrosis 35
The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis 35
Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock 35
Combined untargeted and targeted fingerprinting by comprehensive two-dimensional gas chromatography: revealing fructose-induced changes in mice urinary metabolic signatures 35
Inhibition of IκB kinase attenuates the organ injury and dysfunction associated with hemorrhagic shock 34
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 34
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in mice with CKD 34
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 34
Protective effects of a PPAR-δ agonist and a non-erythropoietic peptide derivative of erythropoietin against the diet-induced development of skeletal muscle insulin resistance and inflammation in mice 34
Endogenous Annexin-A1 is a protective determinant in HFD-induced insulin resistance and diabetic nephropathy 33
Effect of vitamin D on insulin sensibility and myosteatosis in a murine model of diet-induced insulin resistance 33
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 32
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 32
Inhibition of Bruton's TK regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation 32
Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB 32
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice 31
The role of NLRP3 inflammasome as pharmacological target in in vivo models of diabesity and related myocardial ischemic injury 31
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion 31
Ribonuclease 1 attenuates septic cardiomyopathy and cardiac apoptosis in a murine model of polymicrobial sepsis 31
Totale 4.191
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.120 0 0 0 0 200 243 312 54 121 85 104 1
2020/2021705 102 0 98 32 108 4 108 6 108 15 103 21
2021/2022494 10 0 93 77 25 5 20 7 56 5 73 123
2022/20231.360 221 73 49 10 107 46 21 63 761 0 4 5
2023/2024378 3 6 23 19 112 0 97 3 0 8 6 101
2024/202582 11 5 49 10 7 0 0 0 0 0 0 0
Totale 4.384